Bupropion: new therapy for depression

Feinberg, M.

American Family Physician 41(6): 1787-1790

1990


ISSN/ISBN: 0002-838X
PMID: 2112333
Document Number: 351458
Bupropion is one of the most recently approved antidepressant drugs. The drug differs in chemical structure from the tricyclic antidepressants. It mechanism of action is unknown. Bupropion weakly blocks dopamine uptake, but this property does not seem to account for the antidepressant effects. In clinical trials, bupropion has shown satisfactory antidepressant action compared with placebo. Because long-term effects are not well established, bupropion should be discontinued after several months of therapy.

Document emailed within 1 workday
Secure & encrypted payments